Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.
Guillain-Barre Syndrome (pronounced Gee-luhn-Baa Syndrome) or GBS is a rare autoimmune condition in which the immune system attacks the peripheral nerves. It leads to symptoms such as numbness ...